HCA Healthcare reported revenue of $14.97bn in Q3 2022, a decline of 1.98% as against $15.27bn in the corresponding period of 2021.

Net income attributable to the company stood at $1.13bn, or $3.91 per diluted share in third quarter of 2022, a decline of 66.66% as against $2.26bn, or $7.00 per diluted share, in the third quarter of last year.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Results for Q3 2022 include losses on sales of facilities of $3m, while results for Q3 2021 included gains on sales of facilities of $1.04bn, associated to the sale of four hospitals in Georgia and other health care entity investments.

In the third quarter of 2022, adjusted EBITDA totalled $2.90bn, as against $3.2bn in Q3 2021.

Same facility admissions fell 1.5% in Q3 2022, while same facility equivalent admissions grew 2.3% in Q3 2022, compared with the corresponding period of the prior year. Same facility emergency room visits fell 1.3% in Q3 2022, compared with the prior year period, while same facility inpatient surgeries grew 5.6%, and same facility outpatient surgeries rose 2% in the third quarter of 2022, as against the same period of 2021.

The company reported that the same facility revenue per equivalent admission fell 3.5% in Q3 2022, compared with the same period of 2021.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Year over year comparisons were affected by significantly higher Covid-19 volumes in the prior year, when Covid-19 represented 12.7% of same-facility admissions as against 5.2% in the present year quarter.

Revenue for the nine months touched $44.73bn, an increase of 2.37% as against $43.68bn in the same period of 2021.

Net income attributable to the company was $3.56bn, or $11.97 per diluted share, an increase of 36.32% as against $5.14bn, or $15.43 per diluted share, for the first nine months of 2021.

Results for the nine months of 2022 include losses on sales of facilities of $25m, and losses on retirement of debt of $78m.

As of 30 September 2022, HCA Healthcare operated 182 hospitals and around 2,300 ambulatory sites of care in 20 US states and the UK.